Industry: Medical Region: France Transaction price: US$ 1 million Transaction method: equity investment
Project introduction:
A French company hopes to integrate clinical data analysis through digital solutions and improve the management of patients with cardiopulmonary insufficiency, so as to optimize the monitoring of patients' home situation and promote the coordination among medical professionals. The company aims to develop remote monitoring solutions and prediction solutions for the deterioration of chronic obstructive pulmonary disease, so as to make full use of the potential of real data for clinical, research or statistical purposes.
Product introduction:
Simple and easy-to-use integrated home remote monitoring system without patient intervention aims to optimize the nursing process and quality of life. The platform adopts modular design, which can collect the data of respiratory AIDS and measure the vital signs of monitored patients.
Technical advantages of products:
1. Convenient operation
Can be used online through an Internet browser.
Patient management through a simple and intuitive dashboard
Customize alarms based on the collected data and the needs of each patient.
2. Quality and safety
Medical platform certified by CE MDR IIa
Certified to meet ANS requirements (network, interoperability, etc.)
3. Interoperability
It can be easily connected with other platforms (SDK/API) or other connected devices.
Cooperation mode:
Looking for partners who need medical remote monitoring solutions.